Taking people in NetherlandsPhase 1
Tests a glowing dye to help guide brain tumor surgery
Tests a glowing dye, given with 5-ALA, to help surgeons see glioblastoma tissue.
Plain-language title generated from the registry record
Registry title: MIRROR; Multispectral and bimodal fluorescent guided surgery (FGS) of high-grade glioma for refining margin assessment: A phase 1 dose finding study using Cetuximab-IRDye800CW- combined with 5-ALA
Key facts
- Where
- Groningen, NetherlandsSee the site
- Phase
- Phase 1
Where in Netherlands
- UMCGGroningen, NetherlandsTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Universitair Medisch Centrum Groningen
- Trial code
- NCT05929456EU 2024-513392-40-01
- Record updated
- 3 September 2024